Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Kang Wang, Yan‐Jun Xiang, Hongming Yu, Yuqiang Cheng, Zong‐Han Liu, Yingyi Qin, Jie Shi, Wei‐Xing Guo, Chong‐De Lu, Yaxin Zheng, Feiguo Zhou, Mao-Lin Yan, Hongkun Zhou, Chao Liang, Fan Zhang, Wenjing Wei, Wan Yee Lau, Jing‐Jing Li, Yanfang Liu, Shuqun Cheng
Topics & Concepts
MedicineClinical endpointInternal medicineHazard ratioHepatocellular carcinomaAdjuvantAdverse effectRandomized controlled trialPopulationConfidence intervalGastroenterologyIntention-to-treat analysisSurgeryOncologyEnvironmental healthHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyHepatitis B Virus Studies